At 9.3% CAGR, the Europe Lyophilization Services for Biopharmaceuticals Market is projected to be worth US$ 1,244.89 million by 2028, says Business Market Insights

According to Business Market Insights research, the Europe lyophilization services for biopharmaceuticals market was valued at US$ 799.18 million in 2023 and is expected to reach US$ 1,244.89 million by 2028, registering a CAGR of 9.3% from 2023 to 2028. Rising demand for lyophilized products and rapid growth in contract manufacturing and lyophilization services across the region are the critical factors attributed to the Europe lyophilization services for biopharmaceuticals market expansion.        

Biopharmaceutical companies in the lyophilization services market are launching advanced lyophilization technologies to expand their business and maintain a competitive environment in the market. In August 2022, Leadgene Biomedical, Inc., an ISO-certificated contract development and manufacturing organization (CDMO) providing integrated services for in-vitro diagnostics (IVD) products from the development to manufacturing process, launched its LEADSPHERE Lyophilization Technology. The technology aids in dispensing, storing, and transporting reagents for use in biomolecule analysis tools. It also allows assay reagents to be stable in the nonliquid form at room temperature and enables the assembling of the complete kit in a large-scale-production manner through a 'pick and place' automation system. A successful example that uses LEADSPHERE Lyophilization Technology is the LEADSPHERE Proteinase K, an endopeptidase used for nucleic acids sample preparation by inactivating ribonuclease and digesting proteins. LEADSPHERE Proteinase K has been used in applications to specify viruses, such as SARS-CoV-2. The launch of such advanced lyophilization technologies is likely to offer opportunities for the lyophilization services for the biopharmaceuticals market players to attain a significant position in the coming years.

On the contrary, demerits associated with lyophilization process hampers the Europe Lyophilization Services for Biopharmaceuticals Market.  

Based on service type, the Europe lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held 29.23% share of Europe Lyophilization Services for Biopharmaceuticals Market in 2023, amassing US$ 233.56 million. It is projected to garner US$  343.08 million by 2028 to expand at 8.0% CAGR during 2023–2028. 

Based on end user, the Europe lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and other. The pharmaceutical & biotechnology companies segment held 76.17% share of Europe Lyophilization Services for Biopharmaceuticals Market in 2023, amassing US$ 559.13 million. It is projected to garner US$ 956.69 million by 2028 to expand at 9.5% CAGR during 2023–2028.

Based on country, the Europe lyophilization services for biopharmaceuticals market  has been categorized into Germany, UK, France, Spain, Italy, and the Rest of Europe. Our regional analysis states that Germany captured 27.76% share of Europe Lyophilization Services for Biopharmaceuticals Market in 2023. It was assessed at US$ 222.52 million in 2023 and is likely to hit US$ 351.68 million by 2028, exhibiting a CAGR of 9.6% during the forecast period.      

Key players dominating the Europe lyophilization services for biopharmaceuticals market are Berkshire Sterile Manufacturing, Biofortuna, Curia Global Inc, Emergent BioSolutions Inc, Jubilant HollisterStier LLC., PCI Pharma Services, and SYNERLAB GROUP, among others.   

•  In May 2022, Jubilant HollisterStier LLC has entered into a cooperative agreement for US$149.6 million with the Army Contracting Command, in coordination with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEOCBRND) on behalf of the Biomedical Advanced Research and Development Authority (BARDA), within the US Department of Health and Human Services.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com